VRS
SRPT icon

Virginia Retirement Systems’s Sarepta Therapeutics SRPT Stock Holding History

Virginia Retirement Systems’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Buy
28,805
+13,700
+91% +$259K ﹤0.01% 945
2026
Q1 		$329K Buy
15,105
+600
+4% +$11.6K ﹤0.01% 835
2025
Q4 		$312K Buy
+14,505
New +$306K ﹤0.01% 845
2025
Q2 		– Sell
-16,455
Closed -$1.05M – 1067
2025
Q1 		$1.05M Buy
+16,455
New +$1.73M 0.01% 545
2023
Q3 		$1.38M Buy
11,400
+900
+9% +$102K 0.01% 423
2023
Q2 		$1.2M Sell
10,500
-5,600
-35% -$722K 0.01% 492
2023
Q1 		$2.22M Sell
16,100
-1,600
-9% -$208K 0.02% 328
2022
Q4 		$2.29M Buy
17,700
+700
+4% +$81.1K 0.02% 392
2022
Q3 		$1.88M Buy
+17,000
New +$1.71M 0.02% 391
2022
Q1 		$1.35M Buy
17,300
+1,600
+10% +$123K 0.01% 546
2021
Q4 		$1.41M Buy
15,700
+12,800
+441% +$1.09M 0.01% 538
2021
Q3 		$268K Buy
+2,900
New +$223K ﹤0.01% 901
2019
Q4 		– Sell
-8,200
Closed -$618K – 1195
2019
Q3 		$618K Sell
8,200
-5,100
-38% -$602K 0.01% 847
2019
Q2 		$2.02M Buy
13,300
+6,100
+85% +$741K 0.02% 437
2019
Q1 		$858K Sell
7,200
-1,300
-15% -$167K 0.01% 730
2018
Q4 		$928K Sell
8,500
-100
-1% -$12.5K 0.01% 648
2018
Q3 		$1.39M Buy
8,600
+6,300
+274% +$861K 0.02% 582
2018
Q2 		$304K Buy
+2,300
New +$217K ﹤0.01% 982
2018
Q1 		– Sell
-10,200
Closed -$568K – 1053
2017
Q4 		$568K Sell
10,200
-900
-8% -$47.7K 0.01% 782
2017
Q3 		$503K Buy
+11,100
New +$444K 0.01% 811
2014
Q1 		– Sell
-15,400
Closed -$314K – 976
2013
Q4 		$314K Sell
15,400
-11,100
-42% -$330K 0.01% 735
2013
Q3 		$1.25M Buy
+26,500
New +$1.02M 0.03% 374

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Virginia Retirement Systems's SRPT Position: Q2 2026 in Review

Virginia Retirement Systems increased its Sarepta Therapeutics (SRPT) stake by 91% in Q2 2026, buying an estimated $259K and bringing the position to 28,805 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

Virginia Retirement Systems first reported a position in SRPT in Q3 2013 and has held it in 22 quarters since. The position peaked at $2.29M in Q4 2022. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Virginia Retirement Systems held 28,805 shares of Sarepta Therapeutics worth $518K as of Q2 2026.
  • Virginia Retirement Systems bought 13,700 Sarepta Therapeutics shares in Q2 2026, an estimated $259K.
  • Sarepta Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #945 holding.
  • Virginia Retirement Systems first reported a position in Sarepta Therapeutics in Q3 2013 and has held it in 22 quarters since.
  • Virginia Retirement Systems's Sarepta Therapeutics position peaked at $2.29M in Q4 2022.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.